Pioneering Non-Viral RNA Delivery for New Cures
We are a biotech company advancing ionizable lipids and LNP technologies for both preventive and therapeutic RNA therapies. Our Next-gen LNPs offer over 10x greater protein expression; 50% less inflammation; 70% less pain; and non-SORT selective organ targeting. We welcome opportunities to collaborate and drive innovation together!
Transforming RNA delivery: GeneralTx’s Breakthrough LNPs
- Proprietary library of novel ionizable lipids ;
- Enhanced protein expression with selective tissue targeting;
- Minimal systemic toxicity and reactogenicity vs traditional LNPs.
GeneralTx delivers the ultimate LNP solutions for your RNA needs.
Try our QuikLNP® Transfection Kits to simplify and accelerate your xRNA research.
QuikLNP® RNA Transfection Kit
Fast, flexible, and easy to use—QuikLNP® is the most efficient solution for RNA delivery in both in vitro and in vivo research. Achieve high expression, low toxicity, and transferable results—all at a cost-effective price point.
QuikLNP®-Lv Liver Delivery Kit
Effortless and effective—deliver RNA to the liver with just pipetting or vortexing. QuikLNP®-Lv enables high-efficiency in vivo gene editing, making it the ideal tool for liver-targeted screening and validation.
QuikLNP®-Sp Spleen Delivery Kit
Deliver RNA to the spleen with ease using a simple pipetting or vortexing method. Powered by a non-SORT mechanism, QuikLNP®-Sp ensures safe, stable, and reproducible in vivo delivery—ideal for immunotherapy and spleen-targeted research.
QuikLNP®-Ln Lung Delivery Kit
Efficiently deliver RNA to the lung with a simple pipetting or vortexing protocol. Featuring a non-SORT design without cationic lipids, QuikLNP®-Ln offers safe, stable, and reproducible in vivo delivery—perfect for lung-targeted therapeutic research.
QuickLNP®-Tough for Hard-to-Transfect Cells
Easily deliver RNA to challenging cell types with a simple pipetting or vortexing method. QuikLNP®-Tough offers high efficiency and reliable transfection, making your toughest experiments much easier.
Intellectual Property and Freedom to Operate
GeneralTx holds 100% ownership of the IP rights for its proprietary ionizable lipids. We offer flexible licensing options, large-scale lipid manufacturing, and comprehensive LNP research services to support your development needs.
QuikLNP Kits
Our QuikLNP Kit family is a ready-to-use RNA research solution built on our proprietary iLDC LNP platform. Demonstrated with strong proof-of-concept both in vitro and in vivo, QuikLNP Kits are trusted by over 20 leading laboratories worldwide.
QuikLNP RNA Transfection Kit
- Fast LNP formation in seconds for rapid workflow
- Ready-to-use in both in vitro and in vivo applications
- Compatible with a wide range of RNA and DNA types
- Requires only a minimal amount of RNA/DNA for effective delivery
QuikLNP: Accelerating RNA Research
- Ideal for both in vitro and in vivo screening
- Skip Lipofectamine — no more in vitro-only tests with non-transferable data
- Generate highly transferable results for smoother preclinical development
- Screen hundreds of formulations in a single day for rapid optimization
QuikLNP: Quick Organ Targeting
- Target muscle, liver, lung, and spleen with specialized formulations
- Simple mixing—just mix and inject
- Generate highly transferable data for research and development
- Non-SORT solutions offering enhanced safety—ideal for clinical applications
LNP Service Available
- We offer standard formulation materials and customized services to meet your needs.
- Not sure which LNP formulation is right for your project? No problem—schedule a call with our expert team, and we’ll help you find the perfect solution.
Case Studies
Seasonal vaccines with no side effects; Cancer vaccines strong immune response; Gene editing with lower dose and lower inflammation; Non-SORT safer and more effective organ targeting; and more
Non-Reactogenic RNA Vaccines
- 50% reduction in systemic inflammation
- 70% less injection-site pain in vivo
- No observable injection site inflammation
- No muscle damage detected
In Vivo Therapeutics
- Superior expression efficiency for applications like gene editing and protein therapy
- Significantly reduced inflammation and improved liver toxicity profile
- Effective at doses as low as 1/3 to 1/10 of traditional formulations
More Case Data Available
- Our formulations outperform SM-102, ALC-0315, and comparable lipids across all key metrics.
- Interested in detailed data? Contact us via email to learn more.
Product Order
We’ve optimized and fine-tuned every parameter—so you don’t have to.
Ready to accelerate your research? Order now and experience hassle-free RNA delivery.
| Products | Volume (mL) | # of Kit | Price (USD) | |||||
| QuikLNP | One | 0.3 | 1.0 | 3.0 | 1 | 350 | 750 | 1500 |
| Pro | 0.3 | 1.0 | 3.0 | 3 | 800 | 1800 | 3500 | |
| Max | 0.3 | 1.0 | 3.0 | 5 | 1200 | 3000 | 5500 | |
| QuikLNP-Liver | One | 1.0 | 1 | 750 | ||||
| Pro | 1.0 | 3 | 1800 | |||||
| QuikLNP-Spleen | 1.0 | 1 | 1200 | |||||
| QuikLNP-Lung | 1.0 | 1 | Back ordered | |||||
| QuikLNP-Tough | 1.0 | 1 | 1200 | |||||
| Note: Each kit includes all necessary lipids and buffers—just add your RNA. Each 1 mL kit can encapsulate up to 500 µg of RNA, suitable for approximately 50 mice at a 10 µg dose. The recommended minimum volume for mixing is 25 µL of lipid solution with 75 µL of RNA solution. | ||||||||
Want to Learn More?
Connect with our team of experts—bringing over 15 years of experience in nanoparticle RNA delivery—to explore tailored, end-to-end LNP solutions for your RNA research at any scale.